Clinical Trial Update: Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]

View source ↗

Summary

Open-label extension Phase 3 study in patients aged 65 and older with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19